Joel Greenblatt's VCYT Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 69,572 shares of Veracyte, Inc. (VCYT) worth $2.93 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in VCYT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 47,151 shares. Largest reduction occurred in Q1 2023, reducing 58,092 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Veracyte (VCYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veracyte (VCYT) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +47,151 | Add 210.30% | 69,572 | $42.10 |
| Q3 2025 | -10,518 | Reduce 31.93% | 22,421 | $34.33 |
| Q2 2025 | +14,058 | Add 74.46% | 32,939 | $27.03 |
| Q1 2025 | -1,176 | Reduce 5.86% | 18,881 | $29.65 |
| Q4 2024 | +3,549 | Add 21.50% | 20,057 | $39.60 |
| Q3 2024 | +1,448 | Add 9.61% | 16,508 | $34.04 |
| Q2 2024 | +4,619 | Add 44.24% | 15,060 | $21.67 |
| Q1 2024 | -1,081 | Reduce 9.38% | 10,441 | $22.16 |
| Q4 2023 | -33,823 | Reduce 74.59% | 11,522 | $27.51 |
| Q3 2023 | +20,931 | Add 85.73% | 45,345 | $22.33 |
| Q2 2023 | +12,291 | Add 101.39% | 24,414 | $25.47 |
| Q1 2023 | -58,092 | Reduce 82.73% | 12,123 | $22.30 |
| Q4 2022 | +40,706 | Add 137.94% | 70,215 | $23.73 |
| Q3 2022 | -960 | Reduce 3.15% | 29,509 | $16.61 |
| Q2 2022 | +30,469 | New Buy | 30,469 | $19.89 |
| Q4 2021 | -30,299 | Sold Out | 0 | $0.00 |
| Q3 2021 | +30,299 | New Buy | 30,299 | $46.44 |
| Q1 2020 | -9,470 | Sold Out | 0 | $0.00 |
| Q4 2019 | -18,144 | Reduce 65.71% | 9,470 | $27.88 |
| Q3 2019 | -3,618 | Reduce 11.58% | 27,614 | $24.01 |
| Q2 2019 | +31,232 | New Buy | 31,232 | $28.50 |
Joel Greenblatt's Veracyte Investment FAQs
Joel Greenblatt first purchased Veracyte, Inc. (VCYT) in Q2 2019, acquiring 31,232 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Veracyte, Inc. (VCYT) for 21 quarters since Q2 2019.
Joel Greenblatt's largest addition to Veracyte, Inc. (VCYT) was in Q4 2025, adding 69,572 shares worth $2.93 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 69,572 shares of Veracyte, Inc. (VCYT), valued at approximately $2.93 M.
As of the Q4 2025 filing, Veracyte, Inc. (VCYT) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Veracyte, Inc. (VCYT) was 70,215 shares, as reported at the end of Q4 2022.